This document summarizes Dr. Catherine N. Kibirige's presentation on developing ultra-sensitive PCR protocols for HIV vaccine research. It discusses (1) the challenges of HIV's genetic diversity and finding conserved sequence regions for assay design, (2) how digital droplet PCR (ddPCR) was useful for quantifying cell line standards but qPCR was better for analyzing archival patient samples due to issues with ddPCR, and (3) two successful studies using the ultra-sensitive qPCR assay - a pilot study found HIV RNA more frequently in virologically suppressed patients with high inflammation, and characterization of the IAVI Viral Inhibition Assay showed HIV RNA detection within 2 days of differences in CD8 inhibition